Australian (ASX) Growth Pharmaceuticals & Biotech Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Dec 23, 2025

Discover Australian Pharmaceuticals & Biotech Growth Stocks that are on the ASX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

79 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
ARX Aroa Biosurgery	AU$0.71	11.8%	-4.1%	AU$241.5m	n/a	PS3.1x	E104.1%	n/a
TRJ Trajan Group Holdings	AU$0.68	2.3%	-38.4%	AU$106.8m	AU$1.23	PB1x	E85.2%	n/a
BOT Botanix Pharmaceuticals	AU$0.12	4.3%	-69.6%	AU$226.6m	n/a	PS40.8x	E84.2%	n/a
PAR Paradigm Biopharmaceuticals	AU$0.34	9.7%	-9.3%	AU$135.0m	AU$1.38	PB6.9x	E69.6%	n/a
MVP Medical Developments International	AU$0.53	1.0%	29.6%	AU$60.3m	AU$2.29	PE629.2x	E67.1%	0%
VFY Vitrafy Life Sciences	AU$1.35	0%	-22.9%	AU$86.2m	AU$2.18	PS82.3x	E64.0%	n/a
OPT Opthea	AU$0.60	0%	23.7%	AU$738.8m	AU$1.09	PS2307.7x	E56.4%	n/a
MSB Mesoblast	AU$2.90	3.6%	13.7%	AU$3.7b	AU$3.78	PS144.9x	E55.5%	n/a
GSS Genetic Signatures	AU$0.24	0%	-61.9%	AU$53.9m	n/a	PS2.8x	E51.8%	n/a
CU6 Clarity Pharmaceuticals	AU$3.36	4.3%	-16.0%	AU$1.2b	AU$7.40	PS132.1x	E48.0%	n/a
TLX Telix Pharmaceuticals	AU$11.89	1.4%	-52.5%	AU$4.0b	AU$25.97	PE248.8x	E46.9%	n/a
RAD Radiopharm Theranostics	AU$0.027	-3.6%	17.4%	AU$88.6m	n/a	PS7.6x	E45.3%	n/a
ILA Island Pharmaceuticals	AU$0.46	-1.1%	152.8%	AU$123.8m	n/a	PS1029.5x	E32.9%	n/a
PYC PYC Therapeutics	AU$1.70	17.2%	21.4%	AU$909.9m	AU$3.56	PS42.2x	E27.6%	n/a
CUV Clinuvel Pharmaceuticals	AU$12.78	-0.8%	5.2%	AU$658.6m	AU$24.53	PE17.7x	E23.9%	0.4%
IMM Immutep	AU$0.41	6.4%	23.9%	AU$611.6m	AU$1.30	PS121.3x	E23.1%	n/a
NEU Neuren Pharmaceuticals	AU$19.69	-1.1%	61.4%	AU$2.6b	AU$24.96	PE16.7x	E21.8%	n/a
ATH Alterity Therapeutics	AU$0.0085	6.3%	41.7%	AU$92.4m	n/a	PS17x	E20.1%	n/a
IMU Imugene	AU$0.33	1.6%	-73.4%	AU$99.3m	AU$7.21	PS23.3x	E18.4%	n/a
CSL CSL	AU$171.48	-1.1%	-38.9%	AU$84.7b	AU$237.67	PE18.5x	E10.1%	2.5%
RCE Recce Pharmaceuticals	AU$0.61	0%	32.6%	AU$172.1m	AU$2.40	PS23.5x	E0.7%	n/a
TTX Tetratherix	AU$3.31	-2.4%	n/a	AU$164.1m	AU$5.03	PS158.3x	E-0.3%	n/a
IMC Immuron	AU$0.038	-5.0%	-52.5%	AU$12.4m	n/a	PS1.7x	E-5.8%	n/a
CYP Cynata Therapeutics	AU$0.30	8.9%	45.2%	AU$68.9m	n/a	PS38.4x	E-12.5%	n/a

Page 1 of 4